Esomeprazole Magnesium
Product Images NDC 68071-2970

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 68071-2970). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2970 9)

Packaging label for Esomeprazole Magnesium 40mg delayed-release capsules, 90 count, by NuCare Pharmaceuticals, Inc. The label shows the NDC number 68071-2970-9, directions for use, and manufacturing information including Alkerm Laboratories Ltd., India. It also includes warnings, storage instructions, and product identifiers such as lot number and expiration date placeholders.*

FDA Label Image

Esomeprazole-fig2 (Esomeprazole Fig2)

A line graph illustrating the percentage maintained over a six-month period with scheduled visits, comparing esomeprazole magnesium at 40 mg, 20 mg, 10 mg dosages, and a placebo. The vertical axis shows percent maintained, and the horizontal axis shows months from 0 to 6. Each dosage group is represented by distinct markers and line styles, showing higher maintenance percentages for higher esomeprazole doses compared to placebo.*

FDA Label Image

Esomeprazole-fig3 (Esomeprazole Fig3)

A line graph showing the percentage maintained over 6 months for groups receiving Esomeprazole Magnesium at 40 mg, 20 mg, 10 mg doses, and placebo. The vertical axis represents percent maintained, while the horizontal axis shows months with scheduled visits marked. The 40 mg group maintains near 100%, followed by 20 mg and 10 mg groups with lower percentages, and the placebo group declines steeply.*

FDA Label Image

Esomeprazole-fig4 (Esomeprazole Fig4)

A line graph depicting the percent of patients symptom-free over a 28-day diary period, comparing Esomeprazole Magnesium 40 mg, 20 mg, and a placebo. The y-axis shows percent of patients symptom-free, while the x-axis tracks diary days from 0 to 28. Three lines represent each group: circles for 40 mg, triangles for 20 mg, and squares for placebo.*

FDA Label Image

Esomeprazole-fig5 (Esomeprazole Fig5)

A line graph depicting the percent of patients symptom-free over 28 diary days for three groups: Esomeprazole 40 mg, Esomeprazole 20 mg, and Placebo. The vertical axis shows percent symptom-free patients from 0 to 100, and the horizontal axis shows diary days from 0 to 28. Both Esomeprazole groups show higher symptom-free percentages than placebo over time.*

FDA Label Image

Esomeprazole-structure (Esomeprazole Structure)

Chemical structure of the active ingredient Esomeprazole Magnesium, depicted as a dimer complexed with a magnesium ion and three water molecules. The image shows the molecular arrangement including the methoxy groups and sulfoxide functional group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.